Linear Accelerators for Radiation Market - Initiatives By Various Government And Private Organizations In Early Diagnosis Of Cancer | Global Players Including Elekta AB, Siemens Healthcare, Varian Medical Systems, Inc., Accuray Incorporated

A linear accelerator is commonly used in external beam radiation treatments, for patients with cancer. Linear accelerator customizes high energy x-rays or electrons depending on a tumor’s shape and destroys cancer cells while sparing surrounding normal tissue. It is designed with build-up safety features to ensure that it will not deliver a higher dose than prescribed. The linear accelerator is used to treat all parts or organs of the body, by delivering high-energy x-rays or electrons to the region of the patient's tumor. A radiation oncologist prescribes the appropriate treatment volume and dosage of radiation. Furthermore, the medical physicist and the dosimetrist determine how to deliver the prescribed dose and calculate the amount of time it will take the accelerator to deliver that dose. Then, radiation therapists operate the linear accelerator and give patients their daily radiation treatments.

Get FREE In-Depth Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/1855

Linear Accelerators for Radiation Market – Competitor

Some of the key players in the linear accelerators for radiation market include;

1. Elekta AB
2. Siemens Healthcare
3. Varian Medical Systems, Inc.
4. Accuray Incorporated
5. Shinva Medical Instrument Co., Ltd.,

and among other....

Linear Accelerators for Radiation Market Drivers

Increasing number of initiatives by various government and private organizations in early diagnosis of cancer, increases the survival rate, and reduces cancer mortality rate, and this is expected to help to boost market growth of linear accelerators for radiation. For instance, in February 2017, World Health Organization (WHO) proposed new guidelines to improve survival rate of people living with cancer, by ensuring that health service providers can focus on diagnosing and treating the disease earlier. WHO proposed three steps to early diagnosis are: improve public awareness of different cancer symptoms, invest in strengthening and equipping health services and training and ensuring people living with cancer can access safe and effective treatment. Moreover, Cancer Research UK organized Early Diagnosis Research Conference in February 2017, to share and discuss latest developments in early diagnosis research.

Linear Accelerators for Radiation Market – Regional Analysis

Geographically, global linear accelerators for radiation market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. Growing adoption of linear accelerators by prominent cancer treatment centers, worldwide; and upgrading the conventional treatment, will augment growth of the linear accelerators for radiation market, in the near future. In May 2016, Leeds Cancer Centre, a leading providers of cancer care in the U.K. updated its existing treatment equipment with eight Elekta Versa HD linear accelerators. The Versa HD linear accelerators combined with Volumetric Arc Therapy (VMAT) allows to deliver complex head and neck cancer therapy up to 42% faster. Furthermore, in November 2017, Romanian government signed for five Elekta linear accelerators, to supply the country with sophisticated radiation therapy devices. In addition, Princess Margaret Cancer Centre from Canada and Odense University Hospital from Denmark in December 2016, also ordered high-field MR-supported linear accelerator (MR-linac). Both Versa HD linear accelerator and high-field MR-supported linear accelerator (MR-linac) are manufactured by Elekta AB.

Linear Accelerators for Radiation Market – Taxonomy

By Device Type:

Dedicated Linear Accelerator
Non-Dedicated Linear Accelerator

By Therapy:

Intensity-Modulated Radiation Therapy (IMRT)
Volumetric Modulated Arc Therapy (VMAT)
Image Guided Radiation Therapy (IGRT)
Stereotactic Radiosurgery (SRS)
Stereotactic Body Radio Therapy (SBRT)

By Cancer Type:

Lung Cancer
Breast Cancer
Prostate Cancer
Head and Neck Cancer
Colorectal Cancer
Other Cancers

By End User:

Hospitals
Oncology Centres
Cancer Research Institutes

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

For More Details About This Exclusive Research, Talk to Our Analyst @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/1855

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.